Updates in relapsing-remitting MS from AAN 2025 examine neurofilament light protein level as a prognostic biomarker, safety ...

TNF receptor 1 (TNFR1 ... Alzheimer's (AD), Parkinson's (PD), amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS). The presence of this potent inflammatory factor at sites of injury ...

Researchers at the University of Turku, Finland, have discovered a new biomarker that can predict the progression of multiple ...

Multiple sclerosis is a disease that affects the brain and spinal cord, which together form the central nervous system. In multiple sclerosis, the protective covering around nerve fibers ...

The Multiple Sclerosis Treatment Optimization Program (MSTOP) was motivated by research showing that Black and Hispanic ...

More than 280,000 people in Germany have multiple sclerosis (MS) and approximately 15,000 new cases are diagnosed each year.